Literature DB >> 21057535

Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.

K Vuoriluoto1, H Haugen, S Kiviluoto, J-P Mpindi, J Nevo, C Gjerdrum, C Tiron, J B Lorens, J Ivaska.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is a critical event in the progression toward cancer metastasis. The intermediate filament protein vimentin is an important marker of EMT and a requisite regulator of mesenchymal cell migration. However, it is not known how vimentin functionally contributes to cancer cell invasion. Here, we report that ectopic expression of oncogenic H-Ras-V12G and Slug induces vimentin expression and migration in pre-malignant breast epithelial cells. Conversely, vimentin expression is necessary for Slug- or H-Ras-V12G-induced EMT-associated migration. Furthermore, silencing of vimentin in breast epithelial cells results in specific changes in invasiveness-related gene expression including upregulation of RAB25 (small GTPase Rab25) and downregulation of AXL (receptor tyrosine kinase Axl), PLAU (plasminogen activator, urokinase) and ITGB4 (integrin β4-subunit). Importantly, gene expression profiling analyses reveal that vimentin expression correlates positively/negatively with these genes also in multiple breast cancer cell lines and breast cancer patient samples. Focusing on the tyrosine kinase Axl, we show that induction of vimentin by EMT is associated with upregulation of Axl expression and that Axl enhances the migratory activity of pre-malignant breast epithelial cells. Using null and knock-down cells and overexpression models, we also show that regulation of breast cancer cell migration in two- and three-dimensional matrices by vimentin is Axl- dependent and that Axl functionally contributes to lung extravasation of breast cancer cells in mice. In conclusion, our data show that vimentin functionally contributes to EMT and is required for induction of Axl expression. Moreover, these results provide a molecular explanation for vimentin-dependent cancer cell migration during EMT by identifying Axl as a key proximal component in this process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057535     DOI: 10.1038/onc.2010.509

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  261 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

Review 2.  Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function.

Authors:  Jason Lowery; Edward R Kuczmarski; Harald Herrmann; Robert D Goldman
Journal:  J Biol Chem       Date:  2015-05-08       Impact factor: 5.157

3.  Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition.

Authors:  Minsoo Koh; Yunjung Woo; Rajeshwari R Valiathan; Hae Yoen Jung; So Yeon Park; Yong Nyun Kim; Hyeong-Reh Choi Kim; Rafael Fridman; Aree Moon
Journal:  Int J Cancer       Date:  2014-08-30       Impact factor: 7.396

4.  A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone.

Authors:  Simone Bersini; Jessie S Jeon; Gabriele Dubini; Chiara Arrigoni; Seok Chung; Joseph L Charest; Matteo Moretti; Roger D Kamm
Journal:  Biomaterials       Date:  2013-12-31       Impact factor: 12.479

5.  Ras Signaling in Breast Cancer.

Authors:  Aree Moon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.

Authors:  Lauren Averett Byers; Lixia Diao; Jing Wang; Pierre Saintigny; Luc Girard; Michael Peyton; Li Shen; Youhong Fan; Uma Giri; Praveen K Tumula; Monique B Nilsson; Jayanthi Gudikote; Hai Tran; Robert J G Cardnell; David J Bearss; Steven L Warner; Jason M Foulks; Steven B Kanner; Varsha Gandhi; Nancy Krett; Steven T Rosen; Edward S Kim; Roy S Herbst; George R Blumenschein; J Jack Lee; Scott M Lippman; K Kian Ang; Gordon B Mills; Waun K Hong; John N Weinstein; Ignacio I Wistuba; Kevin R Coombes; John D Minna; John V Heymach
Journal:  Clin Cancer Res       Date:  2012-10-22       Impact factor: 12.531

7.  Role of growth arrest-specific gene 6 in the development of fungal allergic airway disease in mice.

Authors:  Takehiko Shibata; Ugur Burcin Ismailoglu; Nicolai A Kittan; Ana Paula Moreira; Ana Lucia Coelho; Geoffrey L Chupp; Steven L Kunkel; Nicholas W Lukacs; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

8.  Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells.

Authors:  Kinga Pénzes; Christine Baumann; István Szabadkai; László Orfi; György Kéri; Axel Ullrich; Robert Torka
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

9.  An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer.

Authors:  Yubo Zhai; Julia Santucci-Pereira; Ricardo Lopez de Cicco; Irma H Russo; Jose Russo
Journal:  Drug Discov Today Dis Mech       Date:  2012

10.  p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.

Authors:  Bangxing Hong; Haiyan Li; Mingjun Zhang; Jingda Xu; Yong Lu; Yuhuan Zheng; Jianfei Qian; Jeffrey T Chang; Jing Yang; Qing Yi
Journal:  Int J Cancer       Date:  2014-05-16       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.